Drug Bidding Practices Challenged By Trump

“Aggressive” is probably a mild term to describe the president-elect’s rhetoric in the days preceding his inauguration. Offensive and damning tweets have been fired off at critics all across social media, with most mainstream news networks focusing on innumerable faux pas and controversial cabinet appointments. Missed on the ides of January is a critically important




Tort Reform, Externalities, and Balance

Now that the new administration plans to throw healthcare back on the table, we’ll surely hear once again about the virtues of tort reform. A perennial conservative salve for seemingly every economic ill, tort reform reduces peoples’ ability to seek redress in court. Hypothetically, tort reform serves as a counterbalance against what the business community



The TPP Is Out, But What About a U.S.-Japanese Free Trade Agreement?

With Trump’s inauguration only a couple days away, some in the political arena are still holding out hope that the Trans-Pacific Partnership (TPP) will survive, despite the fact that Congress effectively put a stop to it, much to President Obama’s dismay. Why did they stop it, though? Was the free trade agreement really so bad? Well, yes and no. While it would have opened up more trade between twelve different nations, a big reason why Congress decided against it was because they shared the concerns of many TPP critics, including President-elect Trump, and were wary of the “pact’s complexity and lack of transparency.” After all, the full text included 30 different chapters.


Pyrrhic Victory for Johnson & Johnson

A Dallas judge’s ruling resulted in a pyrrhic victory for Johnson & Johnson. The latest and possibly last chapter in a long-lasting court case came to a close at the beginning of January. For two years, Johnson & Johnson had been fighting six plaintiffs’ accusations of negligence. At the forefront of the drama was a


Can Your Heart Device Be Hacked?

Heart device users beware. The Homeland Security Department and FDA recently issued warnings about a cybersecurity flaw in one of St. Jude’s medical devices, an implantable heart device. The warning was issued upon discovering that hackers could potentially “take control of a person’s defibrillator or pacemaker” remotely. As if that’s not bad enough, this flaw